MC
WVE icon

Maverick Capital’s Wave Life Sciences WVE Stock Holding History

Maverick Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.38M Buy
1,156,000
+776,000
+204% +$10.1M 0.1% 54
2025
Q4 		$6.46M Hold
380,000
– – 0.07% 59
2025
Q3 		$2.78M Buy
380,000
+23,300
+7% +$189K 0.04% 140
2025
Q2 		$2.32M Buy
+356,700
New +$2.36M 0.03% 110

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Maverick Capital's WVE Position: Q1 2026 in Review

Maverick Capital increased its Wave Life Sciences (WVE) stake by 9.5% in Q1 2026, buying an estimated $11.5M and bringing the position to 10,161,399 shares worth $73.7M. The position accounts for 0.85% of the portfolio, ranked #37.

Maverick Capital first reported a position in WVE in Q1 2021 and has held it in 21 quarters since. The position peaked at $158M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Maverick Capital held 10,161,399 shares of Wave Life Sciences worth $73.7M as of Q1 2026.
  • Maverick Capital bought 881,162 Wave Life Sciences shares in Q1 2026, an estimated $11.5M.
  • Wave Life Sciences made up 0.85% of Maverick Capital's portfolio in Q1 2026, its #37 holding.
  • Maverick Capital first reported a position in Wave Life Sciences in Q1 2021 and has held it in 21 quarters since.
  • Maverick Capital's Wave Life Sciences position peaked at $158M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.